HER2-Peptide Vaccination of Patients With Solid Tumors
Clinical trial NCT02276300 · COMPLETED
Trial details
- NCT number
- NCT02276300
- Sponsor
- Technical University of Munich
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2017-07-18
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.